Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $135.65 million. The enterprise value is $92.00 million.

Market Cap 135.65M
Enterprise Value 92.00M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date May 14, 2026
Ex-Dividend Date n/a

Share Statistics

CNTB has 56.52 million shares outstanding. The number of shares has increased by 0.81% in one year.

Current Share Class 56.52M
Shares Outstanding 56.52M
Shares Change (YoY) +0.81%
Shares Change (QoQ) +0.63%
Owned by Insiders (%) 20.59%
Owned by Institutions (%) 12.55%
Float 12.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2,119.55
Forward PS n/a
PB Ratio 3.23
P/TBV Ratio 3.23
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,437.49
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.02.

Current Ratio 3.74
Quick Ratio 3.27
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -82.72% and return on invested capital (ROIC) is -53.77%.

Return on Equity (ROE) -82.72%
Return on Assets (ROA) -46.13%
Return on Invested Capital (ROIC) -53.77%
Return on Capital Employed (ROCE) -136.77%
Weighted Average Cost of Capital (WACC) 3.23%
Revenue Per Employee $1,000
Profits Per Employee -$866,875
Employee Count 64
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, CNTB has paid $197,000 in taxes.

Income Tax 197,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) -0.18
52-Week Price Change n/a
50-Day Moving Average 2.77
200-Day Moving Average n/a
Relative Strength Index (RSI) 38.97
Average Volume (20 Days) 386,858

Short Selling Information

The latest short interest is 994,618, so 2.62% of the outstanding shares have been sold short.

Short Interest 994,618
Short Previous Month 601,458
Short % of Shares Out 2.62%
Short % of Float n/a
Short Ratio (days to cover) 2.30

Income Statement

In the last 12 months, CNTB had revenue of $64,000 and -$55.48 million in losses. Loss per share was -$1.00.

Revenue 64,000
Gross Profit 64,000
Operating Income -58.07M
Pretax Income -55.28M
Net Income -55.48M
EBITDA -57.37M
EBIT -58.07M
Loss Per Share -$1.00
Full Income Statement

Balance Sheet

The company has $44.34 million in cash and $690,000 in debt, giving a net cash position of $43.65 million or $0.77 per share.

Cash & Cash Equivalents 44.34M
Total Debt 690,000
Net Cash 43.65M
Net Cash Per Share $0.77
Equity (Book Value) 41.98M
Book Value Per Share 0.74
Working Capital 37.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.21 million and capital expenditures -$434,000, giving a free cash flow of -$51.64 million.

Operating Cash Flow -51.21M
Capital Expenditures -434,000
Depreciation & Amortization 704,000
Net Borrowing n/a
Free Cash Flow -51.64M
FCF Per Share -$0.91
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -90,740.63%
Pretax Margin -86,379.69%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.81%
Shareholder Yield -0.81%
Earnings Yield -40.90%
FCF Yield -38.07%

Analyst Forecast

The average price target for CNTB is $8.67, which is 261.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.67
Price Target Difference 261.25%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 193.49%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CNTB has an Altman Z-Score of -7.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.83
Piotroski F-Score 1